Cancer

- Read more about Some heart disease drugs and antibiotics may fight cancer
Certain drugs currently used to treat diseases such as heart failure and cardiac arrhythmia have the potential to be effective in treatment of cancer, new research has found.
7 February 2016

Opening for Ph.D Candidate in Project-Cancer Research in Auckland Cancer Society Research Centre, University of Auckland

The University of Auckland is Founded in 1883, Auckland is the country’s largest university with over 40,000 students, nearly 10,000 of whom graduate annually. The main campus is in the heart of Auckland city and we have four specialist campuses. The only New Zealand university ranked in the top 200 in the Times Higher Education World University Rankings.
- Read more about Can X-rays & CT scans leads to cancer?
The widespread belief that radiations from X-rays and CT scans can cause cancer has flaws and is based on an unproven theoretical model, suggests a study.

[adsense:336x280:8701650588]
- Read more about Cancer cell dies if essential nutrition prevented
Researchers have found that depriving cancer cells of an essential nutrient could offer a promising new approach for the treatment of an aggressive form of kidney cancer.
- Read more about Heart disease, diabetes, cancer may depends on Height
Due to dietary factors, humans are taller now but taller people are more prone to the risk of cancer, warns a recent study.The taller people, though have lower risk for heart disease and Type-2 diabetes, said the study carried out by researchers in Germany.
- Read more about Eat more fruits in adolescence to lower breast cancer risk
Girls who eat more high-fibre foods during adolescence - especially lots of fruits and vegetables may have significantly lower breast cancer risk than those who eat less dietary fibre when young, new research has found.
- Read more about Sun Pharma launched therapeutic equivalent to Novartis' Gleevec in US
Sun Pharma launched therapeutic equivalent to Gleevec® in the US market. Sun Pharma’s subsidiary received final approval for Imatinib Mesylate from FDA in December 2015.
- Read more about Nivolumab with Ipilimumab regimen receives expanded FDA approval
U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable or metastatic melanoma. This indication is approved under accelerated approval based on progression-free survival (PFS). Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
- Read more about NextSource Biotechnology gains FDA approval for new 5 mg strength of Gleostine® (Lomustine), an Anti-Cancer Chemotherapy Agent
NextSource Biotechnology, LLC announced that Gleostine® (lomustine) 5 mg capsules has been approved by the U.S. Food and Drug Administration (FDA) and is now commercially available in the United States.
- Read more about Genmab Announces U.S. FDA Approval of Arzerra® (ofatumumab)
Genmab announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for the use of Arzerra® (ofatumumab) for extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive chronic lymphocytic leukemia (CLL). The application was submitted by Novartis under the ofatumumab collaboration between the two companies.

[adsense:336x280:8701650588]

Subscribe to Cancer

FOR LATEST UPDATES, CLICK TO JOIN OUR WHATS APP GROUP >>

Search

Cancer

RECOMMENDED POSTS

Subscribe with us

Jobs by Category